Journal for ImmunoTherapy of Cancer (Nov 2021)
848 Novel small molecule HPK1 inhibitor PCC-1 induces strong anti-tumor activity
- Nagaraj Gowda,
- Sanjib Das,
- Sravan Mandadi,
- Jagmohan Saini,
- Sachin Chaudhari,
- Ameya Deshpande,
- Murugan Chinnapattu,
- Malini Bajpai,
- Priyanka Pangre,
- Varada Potdar,
- Megha Marathe,
- Pooja Sawant,
- Atul Akarte,
- Chandrasekhar Misra,
- Subhadip Das,
- Anuj Singh,
- Avratanu Das,
- Pandurang Lambade,
- Chaitanya Tirumalasetty,
- Raju Patole,
- Nilanjana Biswas,
- Vikas Karande,
- Heta Shah,
- Dayanidhi Behera,
- Pravin Iyer
Affiliations
- Nagaraj Gowda
- Aff82 grid.464802.cAurigene Discovery Technologies Limited Bangalore Karnataka India
- Sanjib Das
- 1Glenmark Pharmaceuticals Limited, Navi Mumbai, India
- Sravan Mandadi
- 1Glenmark Pharmaceuticals Limited, Navi Mumbai, India
- Jagmohan Saini
- 1Glenmark Pharmaceuticals Limited, Navi Mumbai, India
- Sachin Chaudhari
- 1Glenmark Pharmaceuticals Limited, Navi Mumbai, India
- Ameya Deshpande
- 1Glenmark Pharmaceuticals Limited, Navi Mumbai, India
- Murugan Chinnapattu
- 1Glenmark Pharmaceuticals Limited, Navi Mumbai, India
- Malini Bajpai
- 1Glenmark Pharmaceuticals Limited, Navi Mumbai, India
- Priyanka Pangre
- 1Glenmark Pharmaceuticals Limited, Navi Mumbai, India
- Varada Potdar
- 1Glenmark Pharmaceuticals Limited, Navi Mumbai, India
- Megha Marathe
- 1Glenmark Pharmaceuticals Limited, Navi Mumbai, India
- Pooja Sawant
- 1Glenmark Pharmaceuticals Limited, Navi Mumbai, India
- Atul Akarte
- 1Glenmark Pharmaceuticals Limited, Navi Mumbai, India
- Chandrasekhar Misra
- 2Glenmark Pharmaceuticals, Navi Mumbai, India
- Subhadip Das
- 1Glenmark Pharmaceuticals Limited, Navi Mumbai, India
- Anuj Singh
- 1Glenmark Pharmaceuticals Limited, Navi Mumbai, India
- Avratanu Das
- 1Glenmark Pharmaceuticals Limited, Navi Mumbai, India
- Pandurang Lambade
- 1Glenmark Pharmaceuticals Limited, Navi Mumbai, India
- Chaitanya Tirumalasetty
- 1Glenmark Pharmaceuticals Limited, Navi Mumbai, India
- Raju Patole
- 1Glenmark Pharmaceuticals Limited, Navi Mumbai, India
- Nilanjana Biswas
- 1Glenmark Pharmaceuticals Limited, Navi Mumbai, India
- Vikas Karande
- 1Glenmark Pharmaceuticals Limited, Navi Mumbai, India
- Heta Shah
- 1Glenmark Pharmaceuticals Limited, Navi Mumbai, India
- Dayanidhi Behera
- 1Glenmark Pharmaceuticals Limited, Navi Mumbai, India
- Pravin Iyer
- 1Glenmark Pharmaceuticals Limited, Navi Mumbai, India
- DOI
- https://doi.org/10.1136/jitc-2021-SITC2021.848
- Journal volume & issue
-
Vol. 9,
no. Suppl 2
Abstract
No abstracts available.
